A novel treatment for intermediate dry age-related macular degeneration (AMD), photobiomodulation (PBM) of the retina, has demonstrated good results in clinical trials
It has been studied since the 1970s, with documented effects on wound healing, skin remodeling, and gene expression
These tools not only ignite your bodys natural healing processes but propel you toward your loftiest health goals
Regulatory and safety status: BPC-157 is currently awaiting FDA review
This shapes our peptide protocols: Emphasis on performance, recovery, and cognitive enhancement, not just symptom relief Advanced biomarker tracking beyond standard labs Integration with training, nutrition, and lifestyle optimization Objective outcome measures (body composition, HRV, sleep metrics, performance data) 5